Transforming growth factor-β induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: Abnormalities in cells cultured from benign prostatic hyperplasia tissues

Journal of Endocrinology

Volumn 164, Issue 2, 2000, Pages 215-223

  Cohen, P ^a,c   Nunn, S E ^a   Peehl, D M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY;

EID: 0034049120     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1640215     Document Type: Article

References (44)

1. Angelloz-Nicoud P, Harel L & Binoux M 1996 Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regulation 6 130-136.
2. Angervo M, Koistinen R, Suikkan AM & Seppala M 1991 Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor-I in human granulosa luteal cells. Human Reproduction 6 770-773.
3. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizmger BR & Kley N 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377 646-649.
4. Cazals V, Mouhieddine B, Maitre B, Le Bouc Y, Chadelat K, Brody JS & Clement A 1994 Insulin-like growth factors, their binding proteins, and transforming growth factor-beta 1 in oxidant-arrested lung alveolar epithelial cells. Journal of Biological Chemistry 269 14111-14117.
5. Cohen P, Peehl DM, Lamson G & Rosenfeld RG 1991 Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. Journal of Clinical Endocrinology and Metabolism 73 401-407.
6. Cohen P, Lamson G, Okajima T & Rosenfeld RG 1993 Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Molecular Endocrinology 7 380-386.
7. Cohen P, Peehl DM, Hintz RL & Rosenfeld RG 1994a Insulin-like growth factor axis abnormalities in cultures of prostate stromal cells from patients with benign prostatic hypertrophy. Journal of Clinical Endocrinology and Metabolism 79 1410-1415.
8. Cohen P, Peehl DM & Rosenfeld RG 1994b The insulin-like growth factor axis in the prostate. Hormone and Metabolic Research 26 81-84.
9. Conover CA 1992 Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130 3191-3199.
10. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ & Kim SJ 1994 Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT-1 gene product. Molecular Endocrinology 8 595-602.
11. Dong G, Rajah R, Vu T, Hoffman AR, Rosenfeld RG, Roberts CT Jr, Peele DM & Cohen P 1997 Decreased expression of the Wilm's tumor suppressor gene WT1 and increased 1GF-1I and IGF-1R in the prostatic stroma of patients with benign prostatic hyperplasia. Journal of Clinical Endocrinology and Metabolism 82 2198-2203.
12. Durham SK, Riggs BL & Conover CA 1994 The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta, Journal of Clinical Endocrinology and Metabolism 79 1752-1758.
13. Elgin RG, Busby WH & Clemmons DR 1987 An insulin-like growth factor binding protein enhances the biological response to IGF-I. Proceedings of the National Academy of Sciences of the USA 84 3254-3258.
14. Friedlander P, Haupt Y, Prives C & Oren M 1996 A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Molecular and Cellular Biology 16 4961-4971.
15. Gill ZP, Perks CM, New-comb PV & Holly JM 1997 Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. Journal of Biological Chemistry 272 25602-25607.
16. Gucev ZS, Oh Y, Kelley KM & Rosenfeld RG 1996 Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta 2-induccd growth inhibition in human breast cancer cells. Cancer Research 56 1545-1550.
17. Guo YS, Townsend CM, Jin GF, Beauchamp RD & Thompson JC 1995 Differential regulation by TGF-beta 1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells. American Journal of Physiology 268 E1 199-E1204.
18. Han G-R, Dohi DF, Lee H-Y, Rajah R, Walsh GL, Ki Hong W, Cohen P & Kurie JM 1997 All-trans-retinoic acid increases transforming growth factor-α2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-α-dependent signaling pathway. Journal of Biological Chemistry 272 13711-13719.
19. Hwa V, Oh Y & Rosenfeld RG 1997 Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocrine 6 235-242.
20. Karas M, Danilenko M, Fishman D, LeRoith D, Levy J & Sharoni Y 1997 Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-indiiced insulin-like growth factor-I receptor signaling in Ishikawa endometrial cancer cells. Journal of Biological Chemistry 272 16514-16520.
21. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM & Lee C 1996 Stromal cells of the human prostate: initial isolation and characterization. Prostate 28 89-97.
22. Lalou C, Lassarre C & Binoux M 1996 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137 3206-3212.
23. Leal SM, Liu Q, Huang SS & Huang JS 1997 The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. Journal of Biological Chemistry 272 20572-20576.
24. Ludwig RL, bates S & Vousden KH 1996 Differential activation of target cellular promoters by p53 mutants with unpaired apoptotic function. Molecular and Cellular Biology 16 4952-4960.
25. Martin JL & Baxter RC 1991 Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology 128 1425-1433.
26. Martin JL, Ballesteros M & Baxter RC 1992 Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131 1703-1710.
27. McCusker RH & Clemmons DR 1994 Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro. Endocrinology 134 2095-2102.
28. McNeal JE 1990 Pathology of benign prostatic hyperplasia: insight into etiology. Urologic Clinics of North America 17 477-486.
29. Mohseni-Zadeh S & Binoux M 1997 Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 138 5645-5648.
30. Neuenschwander S, Schwartz A, Wood TL, Roberts CT Jr, Henninghausen L & LeRoith D 1996 Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. Journal of Clinical Investigation 97 2225-2232.
31. Nickerson T, Huynh H & Pollak M 1997 Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochemical and Biophysical Research Communications 237 690-693.
32. Oh Y, Muller HL, Lamson G & Rosenfeld RG 1993a Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. Journal of Biological Chemistry 268 14964-14971.
33. Oh Y, Muller HL, Pham H & Rosenfeld RG 1993b Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T humin breast cancer cells. Journal of Biological Chemistry 268 26045-26048.
34. Oh Y, Muller HL, Ng L & Rosenfeld RG 1995 Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. Journal of Biological Chemistry 270 13589-13592.
35. Peehl DM 1992 Cultures of human prostatic epithelial cells. In Culture of Epithelial Cells, pp 159-180. Ed RI Freshney. New York: Wiley-Liss.
36. Peehl DM & Sellers RG 1997 Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Experimental Cell Research 232 208-215.
37. Rajah R, Valentinis B & Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53-and IGF-independent mechanism. Journal of Biological Chemistry 272 12181-12188.
38. Rechler MM 1997 Growth inhibition by insulin-like growth factor (IGF) binding protein-3 - what's IGF got to do with it? Endocrinology 138 2645-2647.
39. Solberg P & Cohen P 1996 The role of the insulin-like growth factor binding proteins and their proteases in modulating IGF action. Endocrinology and Metabolism Clinics of North America 25 591-614.
40. Story MT, Hopp KA, Meier DA, Begun FP & Lawson RK 1993 Influence of transforming growth factor β1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured humane prostate-derived fibroblasts. Prostate 22 183-197.
41. Tsukazaki T, Usa T, Matsumoto T, Enomoto H, Ohtsuru A, Namba H, Iwasaki K & Yamashita S 1994 Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Experimental Cell Research 215 9-16.
42. Valentinis B, Bhala A, DeAngelis T, Baserga R & Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Molecular Endocrinology 9 361-367.
43. Yateman ME, Claffey DC, Cwyfan Hughes SC, Frost VJ, Wass JA & Holly JM 1993 Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. Journal of Endocrinology 137 151-159.
44. Zadeh SM & Binoux M 1997 The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138 3069-3072.